.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Merck
Teva
Mallinckrodt
Covington
Moodys
Baxter
Daiichi Sankyo
Argus Health
Chubb

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,469,015 protect, and when does it expire?


Patent ► Subscribe protects DENAVIR and is included in one NDA.

This patent has thirty-three patent family members in twenty-seven countries.

Summary for Patent: ► Subscribe

Title: Pharmaceutical formulation
Abstract:An oil-in-water topical pharmaceutical formulation or an aqueous formulation for the treatment of virus infections of the skin or mucosa, comprising at least 30% of propylene glycol and solubilized penciclovir.
Inventor(s): Griffiths; Hazel-Ann (Dorking, GB), Goodall; Alan John (Worthing, GB), Oduro-Yeboah; Joshua (Worthing, GB)
Assignee: Novartis International Pharmaceutical Ltd (Hamilton, BM)
Application Number:08/462,257
Patent Claim Types:
see list of patent claims
Formulation; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mylan Pharms Inc
DENAVIR
penciclovir
CREAM;TOPICAL020629-001Sep 24, 1996RXYesYes► Subscribe► Subscribe TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN ADULTS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2074503► Subscribe
China1053547► Subscribe
China1056058► Subscribe
Cyprus1984► Subscribe
Germany69122229► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Dow
Baxter
Fish and Richardson
Cipla
US Department of Justice
UBS
Queensland Health
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot